Peer review process
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.
Read more about eLife’s peer review process.Editors
- Reviewing EditorSonia SenTata Institute for Genetics and Society, Bangalore, India
- Senior EditorSonia SenTata Institute for Genetics and Society, Bangalore, India
Reviewer #1 (Public review):
In their manuscript Arjun et al. investigate the role of the histone acetyl transferase Gcn5 in controlling Drosophila blood cell homeostasis in the larval lymph gland. Using gcn5 zygotic mutants as well as targeted knock-down and over-expression of Gcn5 in various lymph gland cell populations, they show that these manipulations impact niche cell number, blood cell progenitor maintenance, plasmatocyte differentiation, crystal cell differentiation, DNA damage accumulation. Their results indicate that Gcn5 controls autophagy and show that reducing the expression of the autophagy machinery affect blood cell differentiation. By using drugs as well as genetic approaches to modulate the mTOR pathway, they found that Gcn5 levels are regulated by mTOR, but that the impact of this pathway on blood cell homeostasis can override Gcn5 function.
Overall, the main conclusions are sound. They bring interesting insights into the regulation of autophagy by Gcn5 and mTOR and lay the ground for further dissections of Gcn5 function and mode of action during Drosophila lymph gland development.
Comments on revised version.
The authors have modified the title, abstract and discussion to tune down some of their conclusion and provide a more nuanced interpretation of their data. They have also modified some figure panels as requested.
Reviewer #2 (Public review):
Summary:
Drosophila haematopoiesis has been shown to be governed by a number of signalling pathways such as JAK/STAT and Dpp. This important study shows a role for nutrient sensing and autophagy in determining blood cell differentiation. The authors show that General control non-derepressible 5 (Gcn5), a histone acetyltransferase affects blood cell differentiation. Gcn5 also negatively regulates autophagy through its effector TFEB which directly regulates autophagy genes. The authors also show that mTORC1 modulates Gcn5 levels and through it TFEB activity thus acting as a fine-tuning mechanism which maintains optimal levels of autophagy.
Strengths:
The main strength of the work lies in the interesting finding that cellular metabolic processes such as autophagy has a direct role in blood cell differentiation and has the potential to be of interest to those working on vertebrate haematopoiesis as well. The report has generated intriguing data, using promoters specific for sub sections of the lymph gland, that different cellular subsets of the lymph gland contribute differently towards haematopoiesis, but this is not followed up in detail and the final conclusions are derived from a combination of whole lymph gland perturbations as well as those from specific promoters.
Weakness:
(1) Gc5 seems to be expressed throughout the lymph gland but modulating it in the subsections do not have the same result. It is very striking that the knockdown of Gcn5 in the prohemocyte population does not have an effect on differentiation whereas overexpression does. And the modulations of Gcn5 in PSC also has variable effects across hemocyte subpopulations which is not explored in the manuscript. Interestingly, also the domain deletion constructs show differential effect on blood cell differentiation when altered solely in the prohemocytes which is not explained. While Gcn5 can be seen in all sections of the lymph gland in the first figure, under the HHLT-Gal4 and Hml-Gal4, Gcn5 looks cytoplasmic and almost completely excluded from the nucleus strikingly unlike Gcn5 expression under the Collier-Gal4 and Dome-Gal4. The rest of the experiments in the manuscript are done with multiple promoters, with autophagy flux measured by modulating Gcn5 with a pan hemocyte promoter, but the mTORC1-Gcn5 axis is explored using chemical modulators which affect the whole of the lymph gland (Fig7) or using two pro-hemocyte promoters (Fig8).
(2) The knockdown of Gcn5 seems to affect the gland size (A compared to B and C). Since mTORC1 is a central regulator of cell size, it is possible that some of the effects seen in these knockdowns are potentially through mTORC1 affecting size suggesting that the signalling axis between mTORC1 and Gcn5 might not be a one-way axis as suggested in Figure 9. Also, this would mean that in experiments where absolute cell counts of crystal cells or niche cells are used to assess blood cell differentiation, further analysis to consider total cell numbers in the lymph gland would strengthen the manuscript.
(3) A genetic manipulation of mTORC1 specifically in the pro hemocytes would strengthen the role of mTORC1 in the pathway rather than the chemical modulation which affects the whole of the lymph gland.
Comments on the revised manuscript:
Overall, the revisions make the narrative more coherent and pertinent to the results presented. The authors have also added new data and the analysis supports their conclusions.